Get the content you want anytime you want.

Top Infectious Disease News of the Week—December 31, 2017


#5: What Do Surgeons Need to Know About Intra-Abdominal Infections? Guidance from the Surgical Infection Society

Intra-abdominal infections (IAIs) are defined as disease processes occurring in normally-sterile parts of the abdominal cavity and are generally treated mechanically, such as by surgery. IAIs are common and, despite the medical advances over the past decades, still pose a great risk to the patient, including the risk of death. Beginning in 1992, the Surgical Infection Society (SIS) has published a series of guidelines concerning the treatment of IAIs. The previous guideline was published jointly with the Infectious Diseases Society of America in 2010.

The latest solo version by the SIS, which included an in-depth literature review, was published this past January1. The revision was planned with the intent of addressing the current challenges in treatment of IAIs. These challenges include the increasing prevalence of chronic diseases, which can impair the immune system and decrease the resiliency to infections, societal aging, and the rising global occurrence of bacterial antimicrobial resistance. 

Learn more here.

#4: FDA Gives Marketing Approval to Shock Wave Therapy Device for Diabetic Foot Ulcers

The Dermapace System, the first device designed to treat diabetic foot ulcers with shock wave technology, was recently approved by the US Food and Drug Administration (FDA).

The device, from Sanuwave Health, was previously approved outside of the United States for advanced wound care indications, according to the manufacturing company. Its FDA indication is for the treatment of chronic, full-thickness diabetic foot ulcers, with wound areas measuring no larger than 16 cm2, but without bone exposure.

Read more about the device, here.

Big advances in treatment can